Literature DB >> 22456901

Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients.

Gang Zhou1, Lizhi Niu, David Chiu, Lihua He, Kecheng Xu.   

Abstract

The presence of serum tumor markers, carbohydrate antigen 242 (CA242), carbohydrate antigen 199 (CA199), carbohydrate antigen 125 (CA125), carcinoembryonic antigen (CEA), tumor-supplied group of factors (TSGF) and tumor necrosis factor-α (TNF-α), is closely associated with invasion and metastasis of many malignancies. The expression of these markers were measured in serum taken from 37 pancreatic cancer patients prior to treatment. Levels of CA242, CA199, CA125, CEA and TNF-α expression correlated with tumor size, clinical stage, tumor differentiation, lymph node and liver metastasis (P < 0.05). One month after cryosurgery, serum levels of these markers were significantly reduced compared with levels prior to cryosurgery (P < 0.05), whereas there was no significant difference was found between serum levels before and after chemotherapy (P > 0.05). Thus, cryosurgery is more effective than chemotherapy for decreasing CA242, CA199, CA125, CEA, TSGF and TNF-α serum levels in these patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22456901     DOI: 10.1007/s10529-012-0908-5

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  16 in total

1.  Prognostic factors of carcinoma of the ampulla of Vater after surgery.

Authors:  Jianguo Zhou; Qian Zhang; Peng Li; Yi Shan; Dongbing Zhao; Jianqiang Cai
Journal:  Tumour Biol       Date:  2013-09-12

Review 2.  Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.

Authors:  Yun-Feng Wang; Fei-Ling Feng; Xu-Hong Zhao; Zhen-Xiong Ye; He-Ping Zeng; Zhen Li; Xiao-Qing Jiang; Zhi-Hai Peng
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

3.  Levels of CEA, CA153, CA199, CA724 and AFP in nipple discharge of breast cancer patients.

Authors:  Song Zhao; Yu Mei; Yongmei Wang; Jiang Zhu; Guixi Zheng; Rong Ma
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  Proteome variations in pancreatic stellate cells upon stimulation with proinflammatory factors.

Authors:  Aseel J Marzoq; Nathalia Giese; Jörg D Hoheisel; Mohamed Saiel Saeed Alhamdani
Journal:  J Biol Chem       Date:  2013-10-02       Impact factor: 5.157

5.  Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma.

Authors:  Zi Wang; Ya-Ping Tian
Journal:  Mol Clin Oncol       Date:  2013-12-12

6.  Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.

Authors:  Su-xia Han; Xia Zhou; Xin Sui; Chen-chen He; Meng-jiao Cai; Jin-lu Ma; Yuan-yuan Zhang; Cong-ya Zhou; Chen-xian Ma; Armando Varela-Ramirez; Qing Zhu
Journal:  Oncotarget       Date:  2015-08-14

7.  The mir-675-5p regulates the progression and development of pancreatic cancer via the UBQLN1-ZEB1-mir200 axis.

Authors:  Jue Wang; Youli Zhang; Hong Wei; Xingxing Zhang; Yan Wu; Aihua Gong; Yu Xia; Wenbing Wang; Min Xu
Journal:  Oncotarget       Date:  2017-04-11

8.  Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer.

Authors:  Li Pang; Nan Zhang; Yan Xia; Dawei Wang; Guoqing Wang; Xiangwei Meng
Journal:  Oncotarget       Date:  2016-11-22

9.  Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study.

Authors:  Qiwen Chen; Zhouyu Ning; Lei Wang; Haifeng Ying; Shu Dong; Chenyue Zhang; Xiaoheng Shen; Yuanbiao Guo; Hao Chen; Xiaoyan Zhu; Yehua Shen; Weidong Shi; Yongqiang Hua; Kun Wang; Junhua Lin; Litao Xu; Lianyu Chen; Lanyun Feng; Xiumei Zhang; Jing Xie; Bo Sun; Yaqin Sun; Wenchao Gu; Mei Kang; Zheng Tang; Zhujun Chen; Zhen Chen; Luming Liu; Jinming Yu; Zhaoshen Li; Zhiqiang Meng
Journal:  Oncotarget       Date:  2016-12-20

Review 10.  Translational progress on tumor biomarkers.

Authors:  Hongwei Guo; Xiaolin Zhou; Yi Lu; Liye Xie; Qian Chen; Evan T Keller; Qian Liu; Qinghua Zhou; Jian Zhang
Journal:  Thorac Cancer       Date:  2015-07-27       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.